| CI | Confidence interval |
| CIt | Cumulative incidence for interval t |
| CM | Cutaneous melanoma |
| CsA | Cyclosporine A |
| CNI | Calcineurin inhibitor |
| GS | Glucocorticosteroids |
| IFN-γ | Interferon gamma |
| IL-2 | Interleukin 2 |
| IL-4 | Interleukin 4 |
| IRt | Incidence rate for interval t |
| MPA | Mycophenolic acid (administered as mycophenolate mofetil [MMF] or mycophenolate sodium [MPS]) |
| NF-AT | Nuclear factor of activated T cells |
| NMSC | Non-melanoma skin cancer |
| PNCR | Polish National Cancer Registry |
| PNHF | Polish National Health Fund |
| RD | Risk difference |
| RR | Relative risk |
| SIR | Standardized incidence ratio |
| TAC | Tacrolimus |
| TNF-α | Tumor necrosis factor alpha |